Therapeutics and clinical risk management

Keyphrases

Publications

volume 19, 2023

Rui Zhong, Gang Yu, Yingming Wang, Chao Fang, Shuai Lu, Zhilin Liu, Jingyu Gao, Chengyuan Yan, Qichun Zhao
Research on the Influence of the Allogeneic Bone Graft in Postoperative Recovery After MOWHTO: A Retrospective Study. Therapeutics and clinical risk management 19 (2023)
Van Bang Nguyen, Xuan Nguyen Thi, Hau Nguyen Van Vy, Tuyen Linh Pham Nguyen, Thuy Nguyen Hai, Nguyen Dinh Toan, Chi Van Le
Radiofrequency versus Ethanol Ablation for Single-Session Treatment of Benign Cystic Thyroid Nodules: A Short-Term Retrospective Study. Therapeutics and clinical risk management 19 (2023)
Yeniewa Kerie Anagaw, Marshet Mulugeta Yeheyis, Wondim Ayenew, Gizachew Kassahun Bizuneh
Treatment Outcomes of the Acute Coronary Syndrome Among Patients Attending St. Paul Hospital. Therapeutics and clinical risk management 19 (2023)
Simone Gambazza, Annalisa Orenti, Giovanna Pizzamiglio, Anna Zolin, Carla Colombo, Dario Laquintana, Federico Ambrogi, null null
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry. Therapeutics and clinical risk management 19 (2023)
Chutithep Teekaput, Kanokkarn Teekaput, Kitti Thiankhaw
Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study. Therapeutics and clinical risk management 19 (2023)
Junpeng Wang, Xiaofan Zhang, Mengjun Li, Ruoying Li, Ming Zhao
Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection. Therapeutics and clinical risk management 19 (2023)
Bundit Sawunyavisuth, Chetta Ngamjarus, Kittisak Sawanyawisuth
Adherence to Continuous Positive Airway Pressure Therapy in Pediatric Patients with Obstructive Sleep Apnea: A Meta-Analysis. Therapeutics and clinical risk management 19 (2023)
Gates B Colbert, Hector M Madariaga, Anna Gaddy, Mohamed E Elrggal, Edgar V Lerma
Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy. Therapeutics and clinical risk management 19 (2023)
Stefano Fagiuoli, Pierluigi Toniutto, Nicola Coppola, Domenica Daniela Ancona, Margherita Andretta, Fausto Bartolini, Fulvio Ferrante, Alessandro Lupi, Stefano Palcic, Francesca Vittoria Rizzi, Davide Re, Gema Alvarez Nieto, Candido Hernandez, Francesca Frigerio, Valentina Perrone, Luca Degli Esposti, Alessandra Mangia
Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug-Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). Therapeutics and clinical risk management 19 (2023)
Pietro Castellan, Simone Ferretti, Giulio Litterio, Michele Marchioni, Luigi Schips
Management of Urinary Incontinence Following Radical Prostatectomy: Challenges and Solutions. Therapeutics and clinical risk management 19 (2023)
Zhen Luo, Yansong Li, Xiaoqiang Li, Ren Liao
An Individualized Red Blood Cell Transfusion Strategy Using Pediatric Perioperative-Transfusion-Trigger Score Reduced Perioperative Blood Exposure for Children: A Randomized Controlled Clinical Trial. Therapeutics and clinical risk management 19 (2023)
Tao Zuo, Ping Jiang, Jun Fu, Yongjian Zhang
LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis. Therapeutics and clinical risk management 19 (2023)
Evey Howley, E Graham Davies, Alexandra Y Kreins
Congenital Athymia: Unmet Needs and Practical Guidance. Therapeutics and clinical risk management 19 (2023)
Junpeng Wang, Xiaofan Zhang, Mengjun Li, Ruoying Li, Ming Zhao
Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection. Therapeutics and clinical risk management 19 (2023)
Evey Howley, E Graham Davies, Alexandra Y Kreins
Congenital Athymia: Unmet Needs and Practical Guidance. Therapeutics and clinical risk management 19 (2023)
Zhou-Peng Zheng, Su-Lin Tang, Shao-Lan Fu, Qian Wang, Li-Wei Jin, Yan-Li Zhang, Rong-Rong Huang
Identifying the Risk Factors for Postoperative Sore Throat After Endotracheal Intubation for Oral and Maxillofacial Surgery. Therapeutics and clinical risk management 19 (2023)
Zhou-Peng Zheng, Su-Lin Tang, Shao-Lan Fu, Qian Wang, Li-Wei Jin, Yan-Li Zhang, Rong-Rong Huang
Identifying the Risk Factors for Postoperative Sore Throat After Endotracheal Intubation for Oral and Maxillofacial Surgery. Therapeutics and clinical risk management 19 (2023)
Andrea Melluso, Floriana Secondulfo, Giovanna Capolongo, Giovambattista Capasso, Miriam Zacchia
Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook. Therapeutics and clinical risk management 19 (2023)
Zhijie Li, Mengnan Li, Xiaowei Yao, Bo Liu, Sikai Liu, Zeming Liu, Binquan Zhang, Yong-Tai Han
Bone Remodelling of the Proximal Femur After Hip Revision with a Metaphyseal-Fixation Femoral Stem Component. Therapeutics and clinical risk management 19 (2023)
Stefano Fagiuoli, Pierluigi Toniutto, Nicola Coppola, Domenica Daniela Ancona, Margherita Andretta, Fausto Bartolini, Fulvio Ferrante, Alessandro Lupi, Stefano Palcic, Francesca Vittoria Rizzi, Davide Re, Gema Alvarez Nieto, Candido Hernandez, Francesca Frigerio, Valentina Perrone, Luca Degli Esposti, Alessandra Mangia
Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug-Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). Therapeutics and clinical risk management 19 (2023)
Yanhong Yan, Jiao Geng, Xu Cui, Guiyu Lei, Lili Wu, Guyan Wang
Thoracic Paravertebral Block Decreased Body Temperature in Thoracoscopic Lobectomy Patients: A Randomized Controlled Trial. Therapeutics and clinical risk management 19 (2023)
Pietro Castellan, Simone Ferretti, Giulio Litterio, Michele Marchioni, Luigi Schips
Management of Urinary Incontinence Following Radical Prostatectomy: Challenges and Solutions. Therapeutics and clinical risk management 19 (2023)
Dimitrios D Raptis, Christos S Mantzoros, Stergios A Polyzos
Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease. Therapeutics and clinical risk management 19 (2023)
Christina Shaw, William Gibson
Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder. Therapeutics and clinical risk management 19 (2023)
Christina Shaw, William Gibson
Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder. Therapeutics and clinical risk management 19 (2023)
Nguyen Duy Hung, Nguyen Duy Linh, Nguyen Ha Vi, Nguyen Thi Van Anh, Nguyen Dinh Hieu, Duong Dai Ha, Nguyen Minh Duc
Predictive Value of Preoperative Diffusion Tensor Imaging for Evaluating Postoperative Outcomes of Supratentorial Glioma in the Motor Function Area. Therapeutics and clinical risk management 19 (2023)
Chuang Li, Kuizheng He, Yixing Yang, Kuibao Li, Mulei Chen, Lefeng Wang, Xiaorong Xu, Weiming Li
Nomograms Based on Non-High-Density Lipoprotein to Predict Outcomes in Patients with Prior Coronary Artery Bypass Grafting with Acute Coronary Syndrome: A Single-Center Retrospective Study. Therapeutics and clinical risk management 19 (2023)
Yu Huang, Yilian Xie, Lei Huang, Zhen Han
The Value of Anticoagulation Management Combining Telemedicine and Self-Testing in Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials. Therapeutics and clinical risk management 19 (2023)
Simone Gambazza, Annalisa Orenti, Giovanna Pizzamiglio, Anna Zolin, Carla Colombo, Dario Laquintana, Federico Ambrogi, null null
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry. Therapeutics and clinical risk management 19 (2023)
Nguyen Duy Hung, Nguyen Duy Linh, Nguyen Ha Vi, Nguyen Thi Van Anh, Nguyen Dinh Hieu, Duong Dai Ha, Nguyen Minh Duc
Predictive Value of Preoperative Diffusion Tensor Imaging for Evaluating Postoperative Outcomes of Supratentorial Glioma in the Motor Function Area. Therapeutics and clinical risk management 19 (2023)
Kazuharu Nakagawa, Kanako Yoshimi, Akira Yoshizawa, Kota Aritaki, Kohei Yamaguchi, Ayako Nakane, Haruka Tohara
The Safety of Oral Rehydration Solution Jelly for Water and Electrolyte Intake in Patients with Dysphagia. Therapeutics and clinical risk management 19 (2023)
Zhen Luo, Yansong Li, Xiaoqiang Li, Ren Liao
An Individualized Red Blood Cell Transfusion Strategy Using Pediatric Perioperative-Transfusion-Trigger Score Reduced Perioperative Blood Exposure for Children: A Randomized Controlled Clinical Trial. Therapeutics and clinical risk management 19 (2023)
Rui Zhong, Gang Yu, Yingming Wang, Chao Fang, Shuai Lu, Zhilin Liu, Jingyu Gao, Chengyuan Yan, Qichun Zhao
Research on the Influence of the Allogeneic Bone Graft in Postoperative Recovery After MOWHTO: A Retrospective Study. Therapeutics and clinical risk management 19 (2023)
Yu Huang, Yilian Xie, Lei Huang, Zhen Han
The Value of Anticoagulation Management Combining Telemedicine and Self-Testing in Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials. Therapeutics and clinical risk management 19 (2023)
Hasiya Yusuf, Maria Trent
Management of Pelvic Inflammatory Disease in Clinical Practice. Therapeutics and clinical risk management 19 (2023)
Zhijie Li, Mengnan Li, Xiaowei Yao, Bo Liu, Sikai Liu, Zeming Liu, Binquan Zhang, Yong-Tai Han
Bone Remodelling of the Proximal Femur After Hip Revision with a Metaphyseal-Fixation Femoral Stem Component. Therapeutics and clinical risk management 19 (2023)
Bundit Sawunyavisuth, Chetta Ngamjarus, Kittisak Sawanyawisuth
Adherence to Continuous Positive Airway Pressure Therapy in Pediatric Patients with Obstructive Sleep Apnea: A Meta-Analysis. Therapeutics and clinical risk management 19 (2023)
Hasiya Yusuf, Maria Trent
Management of Pelvic Inflammatory Disease in Clinical Practice. Therapeutics and clinical risk management 19 (2023)
Andrea Melluso, Floriana Secondulfo, Giovanna Capolongo, Giovambattista Capasso, Miriam Zacchia
Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook. Therapeutics and clinical risk management 19 (2023)
Gates B Colbert, Hector M Madariaga, Anna Gaddy, Mohamed E Elrggal, Edgar V Lerma
Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy. Therapeutics and clinical risk management 19 (2023)
Yeniewa Kerie Anagaw, Marshet Mulugeta Yeheyis, Wondim Ayenew, Gizachew Kassahun Bizuneh
Treatment Outcomes of the Acute Coronary Syndrome Among Patients Attending St. Paul Hospital. Therapeutics and clinical risk management 19 (2023)
Giorgio Lorenzo Colombo, Maria Chiara Valentino, Alessandra Fabi, Maria Vittoria Dieci, Mauro Caruggi, Giacomo Matteo Bruno, Gloria Lombardi, Sergio Di Matteo
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy. Therapeutics and clinical risk management 19 (2023)
Dimitrios D Raptis, Christos S Mantzoros, Stergios A Polyzos
Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease. Therapeutics and clinical risk management 19 (2023)
Yanhong Yan, Jiao Geng, Xu Cui, Guiyu Lei, Lili Wu, Guyan Wang
Thoracic Paravertebral Block Decreased Body Temperature in Thoracoscopic Lobectomy Patients: A Randomized Controlled Trial. Therapeutics and clinical risk management 19 (2023)
Maximiliano Diaz-Menindez, Dan Morgenstern-Kaplan, Lyda Cuervo-Pardo, Santiago Alvarez-Arango, Alexei Gonzalez-Estrada
Prevention of Recurrent Attacks of Hereditary Angioedema (HAE): Berotralstat and Its Oral Bioavailability. Therapeutics and clinical risk management 19 (2023)
Ahmed Romdhani, Stephanie Lehmann, Joel Schlatter
Discontinuation of Antidepressants in Older Adults: A Literature Review. Therapeutics and clinical risk management 19 (2023)
Van Bang Nguyen, Xuan Nguyen Thi, Hau Nguyen Van Vy, Tuyen Linh Pham Nguyen, Thuy Nguyen Hai, Nguyen Dinh Toan, Chi Van Le
Radiofrequency versus Ethanol Ablation for Single-Session Treatment of Benign Cystic Thyroid Nodules: A Short-Term Retrospective Study. Therapeutics and clinical risk management 19 (2023)
Chutithep Teekaput, Kanokkarn Teekaput, Kitti Thiankhaw
Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study. Therapeutics and clinical risk management 19 (2023)
Chuang Li, Kuizheng He, Yixing Yang, Kuibao Li, Mulei Chen, Lefeng Wang, Xiaorong Xu, Weiming Li
Nomograms Based on Non-High-Density Lipoprotein to Predict Outcomes in Patients with Prior Coronary Artery Bypass Grafting with Acute Coronary Syndrome: A Single-Center Retrospective Study. Therapeutics and clinical risk management 19 (2023)
Tao Zuo, Ping Jiang, Jun Fu, Yongjian Zhang
LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis. Therapeutics and clinical risk management 19 (2023)